药石科技: 关于提前赎回药石转债的第七次提示性公告

Core Viewpoint - Nanjing PharmaBlock Technology Co., Ltd. has decided to exercise the early redemption of its convertible bonds ("PharmaBlock Convertible Bonds") due to the stock price exceeding the specified threshold, aiming to reduce financial costs and expenses [2][7]. Group 1: Convertible Bond Issuance and Redemption - The company issued 11.5 million convertible bonds at a face value of 100 RMB each, raising a total of 1.15 billion RMB on April 20, 2022 [2][3]. - The convertible bonds were listed on the Shenzhen Stock Exchange on May 18, 2022, under the code "123145" [3]. - The conversion period for the bonds is from October 26, 2022, to April 19, 2028 [3]. - The conversion price was adjusted from 92.98 RMB to 92.88 RMB on June 13, 2022, and further adjustments were made in subsequent years [4][5]. Group 2: Redemption Conditions and Procedures - The early redemption was triggered as the stock price was at least 130% of the conversion price (43.69 RMB) for 15 trading days within the specified period [2][7]. - The redemption price is set at 100.62 RMB per bond, which includes accrued interest calculated based on a 1.5% annual interest rate [8]. - The redemption process includes a series of announcements and a final redemption date of September 18, 2025, after which the bonds will be delisted [9].